GAS5 and neoplasm: Correlated with advanced FIGO stages and other clinicopathological risk factors, colon cancer-associated transcript 2 (CCAT2) is linked to a worse survival rate [192], while growth arrest-specific transcript 5 (GAS5) has been identified as a tumor-suppressive lncRNA in several entities including cervical cancer.